Swiss National Bank Buys Shares of 26,400 ArriVent BioPharma, Inc. (NASDAQ:AVBP)
Swiss National Bank purchased a new position in shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 26,400 shares of the company’s stock, valued at approximately $703,000. Several other hedge […]
